Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Change in Accured Expenses (2022 - 2025)

Oramed Pharmaceuticals' Change in Accured Expenses history spans 4 years, with the latest figure at -$2.0 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses changed N/A year-over-year to -$2.0 million; the TTM value through Dec 2025 reached $944000.0, changed N/A, while the annual FY2025 figure was $1.1 million, 8171.43% up from the prior year.
  • Change in Accured Expenses reached -$2.0 million in Q4 2025 per ORMP's latest filing, down from -$185000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.1 million in Q3 2024 to a low of -$2.0 million in Q4 2025.
  • Average Change in Accured Expenses over 4 years is $105777.8, with a median of $1000.0 recorded in 2023.
  • Peak YoY movement for Change in Accured Expenses: tumbled 80.0% in 2024, then crashed 18600.0% in 2025.
  • A 4-year view of Change in Accured Expenses shows it stood at $329000.0 in 2022, then plummeted by 99.7% to $1000.0 in 2023, then skyrocketed by 309400.0% to $3.1 million in 2024, then plummeted by 163.52% to -$2.0 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Change in Accured Expenses are -$2.0 million (Q4 2025), -$185000.0 (Q1 2025), and $3.1 million (Q3 2024).